New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2014
10:01 EDTVVUS, TRXC, RDS.A, RGDO, OREX, NORD, NNA, INFY, GMAN, HILL, CTSH, BLRX, BP, ARNA, AEGOn The Fly: Analyst Initiation Summary
AEGON (AEG) initiated with a Buy at Deutsche Bank... Arena Pharmaceuticals (ARNA) initiated with a Market Perform at Wells Fargo... BP (BP) initiated with a Buy at Jefferies... BioLineRx (BLRX) initiated with a Buy at Maxim... Cognizant (CTSH) coverage assumed with an Outperform at Credit Suisse... Dot Hill Systems (HILL) initiated with a Buy at Wunderlich... Gordmans Stores (GMAN) initiated with a Buy at Canaccord... Infosys (INFY) assumed with a Buy at Jefferies... Navios Acquisition (NNA) initiated with a Buy at Citigroup... Nord Anglia (NORD) initiated with an Overweight at Barclays... Orexigen (OREX) initiated with an Outperform at Wells Fargo... Regado Biosciences (RGDO) initiated with a Buy at Deutsche Bank... Royal Dutch Shell (RDS.A) initiated with a Hold at Jefferies... TransEnterix (TRXC) initiated with a Buy at Stifel... VIVUS (VVUS) resumed with a Market Perform at Wells Fargo.
News For A;TRXC;VVUS From The Last 14 Days
Check below for free stories on A;TRXC;VVUS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 25, 2014
07:03 EDTVVUSVIVUS acquires patents from Janssen Pharmaceuticals
VIVUS (VVUS) announced the acquisition of a group of patents from Janssen Pharmaceuticals (JNJ) covering uses of topiramate as monotherapy and in combination with other pharmaceutical agents to treat a variety of medical conditions. Janssen has agreed to dismiss the lawsuit it brought against VIVUS on August 22, 2014 in the U.S. District Court for the District of Delaware. VIVUS will pay a one-time upfront fee and a royalty to Janssen on Qsymia product sales for an assignment of these topiramate-related patents owned by Janssen. VIVUS has an option to buy out the royalty for a predetermined amount.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use